Carmot Therapeutics is a U.S.-based biotech company focused on developing incretin-based therapies, including CT-388 (a weekly injectable dual GLP-1/GIP agonist), an oral small-molecule GLP-1 agonist (CT-996), and another injectable GLP-1/GIP candidate (CT-868)
Ismail Kimji, MD, FRCPC, on combined strategy Critique, Methodology, and References Three at-home microinfusion mistakes patients make most often Mistake 01 Stacking actives same day Retinol the night before, AHA the morning of, vitamin C right after, niacinamide before bed
If you have been tolerating each increase without issues, you are building a solid foundation for the next phase
improvements in energy, body composition, and how your clothes fit are also meaningful signs of progress
Instead, we should emphasize one central point: at every eating opportunity, no matter how small, make protein and fiber the priority